Advertiment
Hasegawa S.
Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Malignant pleural mesothelioma (MPM) is a rare thoracic malignancy associated with very poor prognosis. Because no single treatment is very effective for MPM, a combination of preoperative chemotherapy, extrapleural pneumonectomy, and postoperative hemithoracic radiation is currently considered the “standard” therapy for resectable MPM. As such an aggressive protocol involves very high risk, maximum preoperative assessment for durability and curability is required. Very recently, the results of three major clinical trials of trimodality treatment for MPM have been reported from North America and Europe. The therapeutic regimens and results of these trials were similar. Although the overall results were not encouraging, surprisingly good survival rates were noted in patients who had no mediastinal node involvement and completed the entire trimodality therapy regimen. This clearly illustrates that patient selection plays a key role in MPM treatment. Two other important clinical trials are currently ongoing. The Mesothelioma and Radical Surgery (MARS) trial is a randomized clinical trial seeking to clarify the role of radical surgery in MPM treatment. An all-Japan clinical study of trimodality treatment for MPM is currently underway as a part of a national campaign entitled “Comprehensive Strategy against Asbestos-Related Diseases.”
Nippon Geka Gakkai Zasshi. 2009 Nov;110(6):338-42.
Leave a Reply
Suggested Posts
Potential New Treatment For Kidney Cancer By Specific Inhibition Of Autophagy Hasegawa S. Departme t of Thoracic Surgery, Hyogo College of Medici e, Nishi omiya, Japa . Malig a t pleural mesothelioma (MPM) is a rare thoracic malig a cy associated with very poor prog osis. Because o si gle treatme t is very effective for MPM, a combi atio of preoperative chemotherapy, extrapleural p eumo ectomy, a d postoperative hemithoracic radiatio is curre tly co sidered the “sta dard” therapy for resectable MPM. [...]. Posted December 4th, 2009 | 1:56 am
Treatment Of Gynecologic Cancers Reduced From 5 Weeks To 3 Days Using New Radiation Therapy Hasegawa S. Departme t of Thoracic Surgery, Hyogo College of Medici e, Nishi omiya, Japa . Malig a t pleural mesothelioma (MPM) is a rare thoracic malig a cy associated with very poor prog osis. Because o si gle treatme t is very effective for MPM, a combi atio of preoperative chemotherapy, extrapleural p eumo ectomy, a d postoperative hemithoracic radiatio is curre tly co sidered the “sta dard” therapy for resectable MPM. [...]. Posted December 4th, 2009 | 1:56 am
Joint Clinical Practice Guidelines On Hepatocellular Carcinoma Management To Be Published By EASL-EORTC Hasegawa S. Departme t of Thoracic Surgery, Hyogo College of Medici e, Nishi omiya, Japa . Malig a t pleural mesothelioma (MPM) is a rare thoracic malig a cy associated with very poor prog osis. Because o si gle treatme t is very effective for MPM, a combi atio of preoperative chemotherapy, extrapleural p eumo ectomy, a d postoperative hemithoracic radiatio is curre tly co sidered the “sta dard” therapy for resectable MPM. [...]. Posted December 4th, 2009 | 1:56 am
Potential Strategy Aims To Stimulate The Immune System To Defeat Cancers Hasegawa S. Departme t of Thoracic Surgery, Hyogo College of Medici e, Nishi omiya, Japa . Malig a t pleural mesothelioma (MPM) is a rare thoracic malig a cy associated with very poor prog osis. Because o si gle treatme t is very effective for MPM, a combi atio of preoperative chemotherapy, extrapleural p eumo ectomy, a d postoperative hemithoracic radiatio is curre tly co sidered the “sta dard” therapy for resectable MPM. [...]. Posted December 4th, 2009 | 1:56 am
Roche medicine Avastin receives EU approval for the treatment of women with newly diagnosed, advanced ovarian cancer Hasegawa S. Departme t of Thoracic Surgery, Hyogo College of Medici e, Nishi omiya, Japa . Malig a t pleural mesothelioma (MPM) is a rare thoracic malig a cy associated with very poor prog osis. Because o si gle treatme t is very effective for MPM, a combi atio of preoperative chemotherapy, extrapleural p eumo ectomy, a d postoperative hemithoracic radiatio is curre tly co sidered the “sta dard” therapy for resectable MPM. [...]. Posted December 4th, 2009 | 1:56 am